Single Shot Versus OnQ Pump in Extremity Fractures

ClinicalTrials.gov ID: NCT02280291

Public ClinicalTrials.gov record NCT02280291. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 11, 2026, 2:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Comparison Between Single Shot Peripheral Nerve Block and Continuous Infusion Via a On-Q Pump in Extremity Fracture Operations: a Randomized Prospective Control Trial

Study identification

NCT ID: NCT02280291
Recruitment status: Completed
Study type: Interventional
Phase: Phase 4
Lead sponsor: NYU Langone Health; Other
Enrollment: 100 participants

Conditions and interventions

Conditions

Interventions

Ankle OnQ Drug
Ankle SSB Drug
DR OnQ Drug
DR SSB Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 90 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 31, 2013
Primary completion: Dec 12, 2018
Completion: Dec 12, 2018
Last update posted: Mar 29, 2020

2013 – 2018

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Hospital for Joint Diseases	New York	New York	10003	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02280291, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 29, 2020 · Synced May 11, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02280291 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →